Success Metrics

Clinical Success Rate
92.9%

Based on 26 completed trials

Completion Rate
93%(26/28)
Active Trials
1(3%)
Results Posted
65%(17 trials)
Terminated
2(6%)

Phase Distribution

Ph not_applicable
10
30%
Ph early_phase_1
1
3%
Ph phase_1
3
9%
Ph phase_2
7
21%
Ph phase_4
9
27%
Ph phase_3
1
3%

Phase Distribution

4

Early Stage

7

Mid Stage

10

Late Stage

Phase Distribution31 total trials
Early Phase 1First-in-human
1(3.2%)
Phase 1Safety & dosage
3(9.7%)
Phase 2Efficacy & side effects
7(22.6%)
Phase 3Large-scale testing
1(3.2%)
Phase 4Post-market surveillance
9(29.0%)
N/ANon-phased studies
10(32.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

86.7%

26 of 30 finished

Non-Completion Rate

13.3%

4 ended early

Currently Active

1

trials recruiting

Total Trials

33

all time

Status Distribution
Active(1)
Completed(26)
Terminated(4)
Other(2)

Detailed Status

Completed26
Withdrawn2
Terminated2
unknown1
Suspended1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
33
Active
1
Success Rate
92.9%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (3.2%)
Phase 13 (9.7%)
Phase 27 (22.6%)
Phase 31 (3.2%)
Phase 49 (29.0%)
N/A10 (32.3%)

Trials by Status

completed2679%
unknown13%
suspended13%
withdrawn26%
recruiting13%
terminated26%

Recent Activity

Clinical Trials (33)

Showing 20 of 33 trialsScroll for more
NCT05746546Phase 2

Depressed Mood Improvement Through Nicotine Dosing-3 (Depressed MIND3) Extension

Completed
NCT05746273Phase 2

Depressed Mood Improvement Through Nicotine Dosing 3

Completed
NCT06066996Early Phase 1

Evaluation of the Electronic Cigarette Withdrawal Syndrome

Recruiting
NCT00959972Phase 4

Varenicline Versus Transdermal Nicotine Patch for Smoking Cessation in Patients With Coronary Heart Disease

Completed
NCT06218823Phase 4

Tobacco Treatment Comparison for Cancer Care

Completed
NCT04433767Phase 2

Depressed Mood Improvement Through Nicotine Dosing 2

Completed
NCT00775749Not Applicable

Transdermal Nicotine in Female Patients at High Risk for Post Operative Nausea and/or Vomiting (PONV)

Withdrawn
NCT04130698Phase 1

Comparing Two Treatments That Both Target Smoking Cessation and Weight Loss at the Same Time.

Withdrawn
NCT01351766Phase 3

Behavioral Activation Intervention, Reward Processing, and Youth Smoking Cessation

Completed
NCT01199380Phase 2

Behavioral Activation Intervention for Smoking Cessation in Smokers With Depressive Symptoms

Completed
NCT01372254Phase 1

Behavioral Intervention for Low Income Depressed Smokers in Drug Treatment

Completed
NCT00790829Not Applicable

Preemptive Use of the Nicotine Patch for Postoperative Pain Relief After Open Abdominal Surgery

Terminated
NCT02511236Phase 4

Addressing Racial/Ethnic Tobacco Health Disparities Via Group Intervention

Completed
NCT03972137Phase 2

Heart Rate Variability Biofeedback for Smoking Cessation

Completed
NCT02869451Not Applicable

Mobile Contingency Management for Marijuana and Tobacco Cessation

Completed
NCT03072511Phase 4

Smoking Cessation Intervention

Terminated
NCT02453659Not Applicable

Women Engaging in Quitting Smoking Together

Completed
NCT00736255Not Applicable

Attention Deficit Hyperactivity Disorder (ADHD) Smoking Cessation Study

Completed
NCT01362959Phase 4

Nicotine Replacement Therapy in the Intensive Care Unit

Completed
NCT02873754Not Applicable

Smoking Treatment and Exercise Program for Underserved Populations (STEP UP)

Completed

Drug Details

Intervention Type
DRUG
Total Trials
33